PD-L1 is known for its role in enabling immune evasion and advancing tumor progression in diverse tissue types, including pancreatic ductal adenocarcinoma (PDAC), melanoma, non-small cell lung cancer, and renal cell carcinoma [[67], [68], [69]]. Here, CD274 is linked to renal cell carcinoma.